LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

Search

BeiGene Ltd ADR

Open

Sector Healthcare

215.03 -0.86

Overview

Share price change

24h

Current

Min

214.02

Max

218.74

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+27.03 upside

News Sentiment

By Acuity

50%

50%

190 / 389 Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

BeiGene Ltd ADR Chart

Past performance is not a reliable indicator of future results.

Related News

22 Oct 2024, 18:39 UTC

Major Market Movers

Indaptus Therapeutics Shares Rise After Pact to Develop Cancer Treatment

23 Apr 2024, 14:58 UTC

Major Market Movers

BeiGene Shares Rise 7% After European Approval of Tislelizumab Cancer Treatment

13 Mar 2024, 12:42 UTC

Major Market Movers

BeiGene Shares Rise on First Dosing of Brukinsa

7 Aug 2024, 10:05 UTC

Earnings

BeiGene 2Q Loss/Shr $1.15 >BGNE

7 Aug 2024, 10:04 UTC

Earnings

BeiGene 2Q Rev $929M >BGNE

8 May 2024, 10:02 UTC

Earnings

BeiGene 1Q Loss/Shr 19c >BGNE

8 May 2024, 10:01 UTC

Earnings

BeiGene 1Q Loss $251.2M >BGNE

8 May 2024, 10:01 UTC

Earnings

BeiGene 1Q Rev $752M >BGNE

26 Feb 2024, 11:01 UTC

Earnings

BeiGene 4Q Loss/Shr 27c >BGNE

26 Feb 2024, 11:01 UTC

Earnings

BeiGene 4Q Rev $634.4M >BGNE

14 Nov 2023, 04:24 UTC

Market Talk

BeiGene's Global Sales Outlook Brightens -- Market Talk

7 Nov 2023, 02:44 UTC

Market Talk

BeiGene Likely to Post Solid 3Q Sales Growth -- Market Talk

Peer Comparison

Price change

BeiGene Ltd ADR Forecast

Price Target

By TipRanks

27.03% upside

12 Months Forecast

Average 270.33 USD  27.03%

High 307 USD

Low 198 USD

Based on 9 Wall Street analysts offering 12 month price targets forBeiGene Ltd ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

8

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

213.62 / 221.5Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Weak Bullish Evidence

Sentiment

By Acuity

190 / 389 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

$